Media ReleasesImugene Limited

View All Imugene Limited News

Imugene announce Global Biotechnology and Venture Capital Executive Joins Imugene Board

SYDNEY Australia 20 May 2019: The Board of Imugene Limited today announced the appointment of leading biotechnology executive and entrepreneur Dr Jens Eckstein as a Non-Executive Director, effective 20 May 2019.

Dr. Eckstein recently joined Apollo Ventures as Managing Partner. Before that Dr. Eckstein was President of SR One Ltd., the corporate venture capital arm of GlaxoSmithKline which invests globally in emerging life science companies pursuing innovative science with significant impact on medical care and patients.  

For further information please download PDF attached:
Download this document